Comments: NJ A5719 | 2018-2019 | Regular Session

Bill Title: Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2019-08-23 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee [A5719 Detail]

Text: Latest bill text (Introduced) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2018 New Jersey A5719 at this time.

Social Comments on NJ A5719

feedback